In the present study, signal transducer and activator of transcription 3 (STAT3) Ser(#( phosphorylation and transactivation was investigated in relation to activation of mitogen-activated protein (MAP) kinase family members including extracellularsignal-regulated protein kinase (ERK)-1, c-Jun N-terminal kinase (JNK)-1 and p38 (' reactivating kinase ') in response to interleukin (IL)-6 stimulation. Although IL-6 can activate ERK-1 in HepG2 cells, STAT3 transactivation and Ser(#( phosphorylation were not reduced by using the MAP kinase\ERK kinase (MEK) inhibitor PD98059 or by overexpression of dominant-negative Raf. IL-6 did not activate JNK-1 in HepG2 cells and STAT3 was a poor substrate for JNK-1 activated by anisomycin, excluding a role for JNK1 in IL-6-induced STAT3 activation. However, SEK-1\MKK-4 [where SEK-1 stands for stress-activated protein kinase (SAPK)\ERK kinase 1, and MKK-4 stands for MAP kinase kinase 4] was activated in response to IL-6 and overexpression of dominant-negative SEK-1\MKK-4(A-L) reduced
INTRODUCTION
Interleukin (IL)-6 is a pleiotropic cytokine that mediates a variety of functions in different cells and tissues including proliferation and differentiation of haematopoietic cells, induction of the acute-phase response in liver cells and inflammation at sites of tissue injury [1] [2] [3] . IL-6 initiates its action by binding to its receptor which is composed of two subunits : an 80-kDa IL-6 binding protein and a 130-kDa transmembrane signaltransducing component (gp130) [4] [5] [6] . The gp130 receptor protein is also used by other members of the IL-6 cytokine family, including IL-11, oncostatin M, leukaemia inhibitory factor, and ciliary neurotrophic factor [7] [8] [9] . Activation of IL-6 signal transduction involves gp130 dimerization, ligand-dependent tyrosine phosphorylation of the gp130-associated protein-tyrosine kinases Jak1, Jak2 and Tyk2, as well as tyrosine phosphorylation of signal transducer and activator of transcription 3 (STAT3) [10] . Tyrosine phosphorylation of STAT3 occurs at a single residue (Tyr(!&) which is located in a conserved Src homology 2 (SH2) domain allowing homodimerization as well as heterodimerization with other STAT family members, nuclear translocation and transcription activation following binding to specific consensus sequences of target-gene promoters [10] . In addition to tyrosine phosphorylation, STAT3 is serine phosphorylated at a single residue (Ser(#() in response to IL-6 as Abbreviations used : STAT3, signal transducer and activator of transcription 3 ; MAP, mitogen-activated protein ; ERK, extracellular-signal-regulated protein kinase ; JNK, c-Jun N-terminal kinase ; IL, interleukin ; MEK, MAP kinase/ERK kinase ; SAPK, stress-activated protein kinase ; SEK-1, SAPK/ERK kinase 1 ; MKK-4, MAP kinase kinase 4 ; MEKK, MEK kinase ; EGF, epidermal growth factor ; SH, Src homology ; FCS, foetal calf serum ; HA, haemagglutinin ; IRE, IL-6 response element ; TPA, 12-O-tetradecanoylphorbol-13-acetate. 1 To whom correspondence should be addressed (e-mail W.Kruijer!biol.rug.nl).
both IL-6-induced STAT3 Ser(#( phosphorylation as well as STAT3 transactivation. Subsequently, the SEK-1\MKK-4 upstream components Vav, Rac-1 and MEKK were identified as components of a signal transduction cascade that leads to STAT3 transactivation in response to IL-6 stimulation. Furthermore, inhibition of p38 kinase activity with the inhibitor SB203580 did not block STAT3 Ser(#( phosphorylation but rather increased both basal as well as IL-6-induced STAT3 transactivation, indicating that p38 may act as a negative regulator of IL-6-induced STAT3 transactivation through a presently unknown mechanism. In conclusion, these data indicate that IL-6-induced STAT3 transactivation and Ser(#( phosphorylation is independent of ERK-1 or JNK-1 activity, but involves a gp130 receptorsignalling cascade that includes Vav, Rac-1, MEKK and SEK-1\MKK-4 as signal transduction components.
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well as other extracellular factors including interferon-γ and epidermal growth factor (EGF) [11, 12] . Ser(#( phosphorylation has been shown to enhance STAT3 transcriptional activation [12] . At present, the signalling events downstream of the gp130 receptor have not been fully explored and the kinase responsible for IL-6-induced STAT3 Ser(#( phosphorylation has not been identified. Mitogen-activated protein (MAP) kinases consist of a family of serine\threonine kinases, positioned at the end-point of signal transduction cascades initiated at the plasma membrane by ligand-receptor interaction [13] . Several mammalian MAP kinases have been identified, including extracellular-signalregulated protein kinase (ERK) [14] , stress-activated protein kinase or c-Jun N-terminal protein kinase (SAPK\JNK) [15, 16] , and p38 (' reactivated kinase ') [17, 18] . The activation of ERKs involves a signal transduction pathway that includes Ras, Raf-1 and MAP kinase\ERK kinase (MEK) downstream of receptor tyrosine kinase receptors [19] [20] [21] . JNKs are activated by ' stress stimuli ' involving a signal transduction pathway that contains Ras, Rac-1, MEK kinase (MEKK) and SEK-1\MKK-4 (where SEK-1 stands for SAPK\ERK kinase 1 and MKK-4 stands for MAP kinase kinase 4) [22] [23] [24] [25] [26] [27] [28] . The signalling pathway that leads to the activation of p38 is not fully elucidated, but MKK3 and MKK6 have been identified as MKKs for p38 [29, 30] . Upon activation, MAP kinases rapidly translocate to the nucleus and have been shown to phosphorylate several transcription factors including Elk which is phosphorylated by ERK-1 [31, 32] and cJun, ATF-2 and Sap-1 which are substrates for activated JNK [31, 33, 34] .
Although signalling events downstream of the gp130 receptor have not fully been elucidated, gp130 has been shown to interact with Vav [35] , a 95-kDa proto-oncogene product that is expressed in haematopoietic cells and trophoblasts [36, 37] . Vav contains an array of structural motives, including zinc finger, leucine zipper, pleckstrin homology, Dbl homology and SH2 and SH3 domains [37, 38] . In addition, Vav has been identified as a substrate for receptor-and non-receptor tyrosine kinases while tyrosine phosphorylated Vav has recently been shown to catalyse GDP\ GTP exchange on Rac-1, which leads to activation of JNK [35, 39, 40] .
In the present study, we have investigated the involvement of the ERK, JNK and p38 signalling pathways in IL-6-induced STAT3 Ser(#( phosphorylation and transactivation. Our results demonstrate that STAT3 Ser(#( is not a direct target for phosphorylation by ERK, JNK or p38. However, IL-6-induced STAT3 Ser(#( phosphorylation involves activated SEK-1\MKK-4 as well as Vav, Rac and MEKK as gp130 receptor downstream components. The uncoupling between SEK-1\MKK-4 and JNK activation in response to IL-6, as well as the role of p38 in this process, will be discussed.
MATERIALS AND METHODS

Cell culture, reagents and antibodies
The human hepatoma cell line, HepG2, was grown in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) heatinactivated foetal calf serum (FCS ; Integro B. V., Zaandam, The Netherlands). Cells were stimulated with 25 ng\ml human recombinant IL-6 (generous gift from Dr S. C. Clark, Genetics Institute, Cambridge, MA, U.S.A.), 100 ng\ml 12-O-tetradecanoylphorbol-13-acetate (TPA ; Sigma), or 100 ng\ml anisomycin (Sigma). The MEK inhibitor PD98059 (Santa Cruz) and the p38 inhibitor SB203580 (a gift from Dr J. C. Lee 
Expression and reporter constructs
The following plasmids were used : pIRE LUC containing two copies of the IL-6 response element (IRE) of the ICAM-1 promoter in front of the herpes simplex virus thymidine kinase promoter and the luciferase gene [41] ; pSG5-STAT3 which expresses STAT3 from the SV40 promoter ; pSG5-STAT3β, which expresses a dominant-negative isoform of STAT3 lacking the 55 C-terminal amino-acid residues ; pSG5-STAT3 Ser(#( Ala, which expressed a mutant STAT3 in which the Ser(#( is replaced by Ala ; pCS2j-RacN17 and pCS2j-RacV12 expressing the dominant-negative and constitutive-active mutant variants of Rac ; pSEK-1\MKK-4(A-L) which expresses dominant-negative SEK-1\MKK-4 [42] ; pCDNA3-MEKK∆(K432M) which expresses a dominant-negative MEKK [43] ; pCDNA3-HA-JNK-1 which expresses HA-tagged JNK-1 (p46) ; pGEX-1-cJun(1-135) expressing glutathione S-transferase (GST)-c-Jun ; and the dominant-negative and constitutive-active mutants pEFmyc-Vav-C [44] and pMEX-myc-Vav-A(∆1-65) [39, 45] . The expression vector encoding a dominant-negative mutant of Raf kinase, N∆Raf, was provided by Dr P. Coffer (Department of Pulmonary Diseases, University Hospital Utrecht, Utrecht, The Netherlands) [46] . The pGEX-STAT3(379-770) expression vector was cloned by inserting the BamHI-BglII (blunt) pSG5-STAT3 fragment into the BamHI and SmaI sites of pGEX-4t1.
Transient transfections
HepG2 cells were seeded at 3i10& cells per well in 6-well plates (Costar), and 24 h later cells were transfected with 10 µg of plasmid DNA using the calcium phosphate co-precipitation method [46] . Transfection mixtures consisted of a mixture of 3 µg of pIRE LUC reporter, 3 µg of pDM2LacZ as a control to determine transfection efficiency, and 1-4 µg of expression plasmids for dominant-negative or constitutive-active signal transduction components, as mentioned in the results section. When necessary, pUC18 was added to the transfection mixture to obtain a total of 10 µg of DNA. Cells were incubated with precipitate for 24 h, washed with PBS, and stimulated for an additional 24 h. Cells were collected in 200 µl of reporter lysis buffer (Promega) and subjected to the assays for luciferase [46, 47] and β-galactosidase [46, 48] as described previously. The data represent two independent experiments using different batches of DNA, and in each experiment transient transfections were performed in triplicate. Standard deviations were calculated using Sigmaplot (Jandel Corp.).
SDS/PAGE, Western blotting, immunoprecipitations and kinase assays
A total of 1i10( cells were lysed on ice in lysis buffer [20 mM Hepes, pH 7.4, 2 mM EGTA, 1 mM dithiothreitol, 1 mM Na # VO $ (ortho), 1 % (v\v) Triton X-100, 10 % (v\v) glycerol, 10 µg\ml leupeptin, 0.4 mM PMSF]. Prior to SDS\PAGE and immunoprecipitations, protein concentrations were determined (Bio-Rad) and equal amounts were used in the experiments. Whole-cell extracts were boiled for 5 min in the presence of Laemmli sample buffer prior to separation on SDS\12.5 % (w\v) polyacrylamide gels. The proteins were transferred to a nitrocellulose filter (Millipore) in Tris\glycine buffer at 100 V for 1.5 h using an electroblotter (Pharmacia). Membranes were blocked with PBS buffer containing 5 % (w\v) non-fat milk prior to incubation with antibodies. Binding of each antibody was detected by chemiluminesence using ECL2 according to the manufacturer's recommendations (Amersham Corp.). For immunoprecipitations, whole-cell lysates were incubated with anti-Vav or anti-HA antibodies, precipitated with Protein ASepharose beads (Pharmacia), and washed two times with lysis buffer. The precipitates were boiled for 5 min in Laemmli sample buffer and subjected to SDS\PAGE (12.5 % gel). For kinase assays, JNK-1 was precipitated with Protein A-Sepharose beads, washed three times with lysis buffer, two times with LiCl buffer (500 mM LiCl, 100 mM Tris\HCl, pH 7.6, 0.1 % Triton X-100, and 1 mM dithiothreitol), and three times with assay buffer (20 mM Mops, pH 7.2, 2 mM EGTA, 10 mM MgCl # , 1 mM dithiothreitol, 0.1 % Triton X-100). The precipitates were incubated for 30 min in 43.5 µl of assay buffer, 20 mM MgCl # , 25 µM ATP, 10 µCi of [γ-$#P]ATP, and 5 µg of GST-cJun(1-135), 5 µg of myelin basic protein (Santa Cruz) or 5 µg of GST-STAT3(379-770). Beads were boiled in SDS\sample buffer for 5 min and separated on an SDS\12.5 % polyacrylamide gel. The gel was dried and phosphorylation of the GST substrates was detected by autoradiography. Interleukin-6-induced STAT3 transactivation
RESULTS
IL-6-induced STAT3 Ser 727 phosphorylation is not mediated by ERK-1 or JNK-1
Previously, it has been demonstrated that activation of STAT3 in response to IL-6 is dependent on phosphorylation of both tyrosine and serine amino acid residues [10] [11] [12] . STAT3 serine phosphorylation involves a single residue, Ser(#( , that is located at the extreme C-terminus. To study the kinetics of STAT3 phosphorylation, HepG2 cells were stimulated with IL-6 and Tyr(!& and Ser(#( phosphorylation was examined by Western blotting using STAT3 phospho-specific antibodies. STAT3 Ser(#( phosphorylation was observed within 10 min upon IL-6 stimulation of HepG2 cells, whereas STAT3 Tyr(!& phosphorylation was observed within 5 min ( Figure 1A ). Overexpression of STAT3β or a STAT Ser(#(Ala mutant strongly decreased transactivation of the pIRE LUC reporter, which contained two copies of the IRE of the ICAM-1 promoter ( Figure 1B ). This
Figure 1 IL-6-induced STAT3 transactivation is not mediated via ERK-1 in HepG2 cells
(A) HepG2 cells (3i10 6 ) were grown on 92-mm-diameter Petri dishes, starved of serum overnight in medium containing 0.1 % FCS, and stimulated with 25 ng/ml IL-6 for various time periods. Equal amounts of whole-cell lysates were Western blotted using antibodies against 
Figure 2 IL-6 does not activate JNK-1 in HepG2 cells
(A) HepG2 cells (3i10 6 ) were grown on 92-mm-diameter Petri dishes, starved of serum overnight in medium containing 0.1 % FCS, and stimulated with 25 ng/ml IL-6 or 100 ng/ml anisomycin (Ani) as indicated. Cell lysates were subjected to immunoprecipitation using anti-JNK1 antibodies and Protein A-Sepharose beads, and precipitates were used in kinase assays in vitro using 5 µg of GST-c-Jun(1-135) as a substrate, as described in the Materials and methods section. As a control, the same amounts of protein used in the kinase assay were subjected to Western blotting and probed with anti-JNK-1 antibody. indicates that specific phosphorylation on the Ser(#( residue of STAT3 is important for maximal STAT3 transcriptional activation. Since Ser(#( is located in a conserved Pro-Xaa-Ser\ Thr-Pro site, which has been accepted as a phosphorylation site for MAP kinases [49] , the involvement of the ERK, JNK and p38 MAP kinases in STAT3 Ser(#( phosphorylation was investi- were Western blotted and overexpressed proteins were visualized using anti-SEK-1/MKK-4 antibodies. Endogenous SEK-1/MKK-4 was detectable in untransfected cells (u), but the overexpression is clearly visible. As a control, blots were stripped and reprobed with gated. Previous reports have indicated that IL-6-induced STAT3 Ser(#( phosphorylation is an ERK-1-independent process [41, 50] , and we have been able to confirm these results in HepG2 cells. Blocking ERK activation by overexpression of dominant-negative Raf, N∆Raf [46] , or by using the MEK inhibitor PD09859 did not alter STAT3 Ser(#( phosphorylation or transactivation (results not shown). To determine the role of JNK-1 in IL-6-induced STAT3 Ser(#( phosphorylation, JNK-1 was immunoprecipitated from IL-6-induced HepG2 cells and its activity was determined by kinase assays in itro using GST-c-Jun(1-135) as a substrate. JNK was activated only slightly by IL-6 in serumstarved HepG2 cells, whereas anisomycin strongly increased JNK activity under the same conditions (Figure 2A) . In HepG2 cells cultured in 10 % FCS, IL-6 did not induce JNK activity over a high basal level activity ( Figure 2B) . Overexpression of the wild-type p46 isoform of JNK-1 did not alter transactivation of the pIRE LUC reporter, indicating that increased expression of JNK-1 does not result in increased levels of STAT transactivation ( Figure 2C ). In addition, using GST-STAT3(379-770) as a substrate for immunoprecipitated JNK-1 or ERK-1 from IL-6 or TPA stimulated HepG2 cells, no phosphorylation of STAT3 was detected (results not shown). Taken together, these results strongly suggest that neither JNK-1 nor ERK-1 are responsible for IL-6-induced STAT3 Ser(#( phosphorylation and hence STAT3-dependent pIRE LUC reporter activation.
IL-6 activates SEK-1/MKK-4, which mediates IL-6-induced STAT3 transactivation
Although JNK-1 is not activated in response to IL-6, we further investigated the involvement of the SAPK\JNK pathway in IL-6-induced STAT3 transactivation. SEK-1\MKK-4 is located upstream of JNK-1 and its activation upon IL-6 stimulation was determined. IL-6-induced SEK-1\MKK-4(Thr##$) phosphorylation within 5 min as determined by Western blotting using specific antibodies against phosphorylated SEK-1\MKK-4(Thr##$) ( Figure 3A) . Maximal SEK-1\MKK-4 phosphorylation was detected at 10 min and phosphorylation decreased to undetectable levels upon 20 min of IL-6 stimulation ( Figure 3A) . Since SEK-1\MKK-4 is activated in response to IL-6, the effect of overexpression of a dominant-negative mutant of SEK-1\MKK-4(A-L) [42] lanes 9 and 10) . After an overnight incubation with the DNA precipitate cells were washed and stimulated with 25 ng/ml IL-6 for 15 min. HA-STAT3 was immunoprecipitated using anti-HA antibodies and precipitates were Western blotted using antibodies against phosphorylated STAT3(Ser 727 and Tyr 705 ). As a control, blots were stripped and reprobed with anti-HA antibodies. Interleukin-6-induced STAT3 transactivation ation was unaffected ( Figure 3C, lanes 1-4) . These results demonstrated that SEK-1\MKK-4 was activated in HepG2 in response to IL-6 and indicated that activation of SEK-1\MKK-4 was important in IL-6-induced STAT3 transactivation and Ser(#( phosphorylation.
The SEK-1/MKK-4 upstream components Vav, Rac-1 and MEKK-1 are involved in IL-6-induced STAT3 transactivation
Previously, it has been shown that Vav associates with the gp130 receptor upon IL-6 stimulation [35] . Since Vav is capable of activating Rac-1 [40] and Rac-1 is a known activator of the JNK pathway [23, 28, 39] , the involvement of Vav and Rac-1 in IL-6-induced STAT3 transactivation and Ser(#( phosphorylation was investigated. Vav tyrosine phosphorylation was increased from undetectable levels in unstimulated HepG2 cells to maximal levels after 10 min of IL-6 stimulation ( Figure 4A ). Furthermore, transient co-transfection of the pIRE LUC reporter together with a vector expressing dominant-negative Vav-C [39] decreased IL-6-induced STAT3 reporter transactivation from 7.7p0.6-fold to 3.5p0.2-fold, while constitutive-active Vav-A (∆1-65) [39] increased IL-6-induced STAT3 transactivation from 7.7p0.6-fold to 10.4p0.1-fold ( Figure 4B ). These results indicate that Vav acts downstream of the gp130 receptor in IL-6-induced STAT3 transactivation. To investigate the association between Vav and Rac-1 upon IL-6 stimulation, Vav was immunoprecipitated from HepG2 cell lysates and Vav-associated proteins were analysed by Western blotting. Rac-1 transiently co-precipitates with Vav, which is maximal after 5 min and is followed by a quick release of Rac-1 that is complete after 20 min ( Figure  4A ). Since Vav acts as a GDP\GTP exchange factor for Rac-1, by releasing it in the active GTP-bound form, we investigated the effects of constitutive-active and dominant-negative Rac-1 variants on IL-6-induced STAT3 transactivation. IL-6-induced STAT3 transactivation of the pIRE LUC reporter was reduced in a dose-dependent manner by overexpression of dominantnegative RacN17 from 7.9p0.7-fold to 4.6p0.2-fold ( Figure  4C ). As expected, constitutive-active RacV12 strongly increased both basal as well as IL-6-induced STAT3-dependent activation of the pIRE LUC reporter ( Figure 4C ).
To further investigate the involvement of SEK-1\MKK-4 in IL-6-induced STAT3 transactivation, the influence of SEK-1\MKK-4 upstream kinases on STAT3 transactivation was studied. Since MEKK-1 has been shown to be an upstream activator of SEK-1\MKK-4 in many cell types, a dominantnegative mutant MEKK∆(K432M) was expressed in HepG2 cells together with the pIRE LUC reporter [43] . Overexpression 6 ) were grown on 92-mm-diameter Petri dishes, starved of serum overnight in medium containing 0.1 % FCS and stimulated with 25 ng/ml IL-6, 100 ng/ml TPA, or preincubated with 1 µM SB203580 before stimulation, as indicated. Cell lysates were subjected to immunoprecipitation using anti-p38 antibodies and Protein A-Sepharose beads and kinase assays were performed in vitro using 5 µg of myelin basic protein as a substrate as described in the Materials and methods section. As a control, the same amounts of protein used in the kinase assays were subjected to Western blotting and probed with anti-p38 antibody. (B) HepG2 cells (3i10 5 ) were transfected with 3 µg of pIRE LUC reporter, 3 µg of pDM2LacZ and 4 µg of pUC18 to obtain a total of 10 µg of DNA. Cells were preincubated with 0-2 µM SB203580 for 60 min, and either unstimulated (open bars) or stimulated with 25 ng/ml IL-6 (filled bars) for 24 h until harvest. (C) HepG2 cells (3i10 6 ) were grown on 92-mm-diameter Petri dishes, starved of serum overnight in medium containing 0.1 % FCS, and stimulated with 25 ng/ml IL-6 for various time periods. Where indicated, cells were preincubated for 1 h with 1 µM SB203580 prior to stimulation. Equal amounts of whole-cell lysates were Western blotted using antibodies against STAT3 and phosphorylated STAT3(Ser 727 and Tyr 705 ).
of dominant-negative MEKK-1 strongly reduced IRE transactivation from 7.9p0.7-fold to 3.5p0.1-fold ( Figure 4C) . Furthermore, the increased IRE transactivation by overexpression of RacV12 could be blocked by overexpression of dominant-negative MEKK∆(K432M) or SEK-1\MKK-4(A-L),
indicating that MEKK and SEK-1\MKK-4 act downstream of Rac in the IL-6-induced signal transduction cascade ( Figure 4C) . Also, the increased IRE transactivation in the presence of overexpressed constitutive-active Vav-A could be blocked by overexpression of dominant-negative RacN17, MEKK∆(K432M) or SEK-1\MKK-4(A-L), indicating that Rac, MEKK-1 and SEK-1\MKK-4 act downstream of Vav in the IL-6-induced IRE transactivation ( Figure 4B ). To correlate the effects of dominant-negative Vav-C, Rac-V12 and MEKK∆(K432M) on STAT3 transactivation at the level of STAT3 Ser(#( phosphorylation, HA-tagged STAT3 constructs were co-transfected in HepG2 cells together with vectors expressing dominant-negative Vav-C, Rac-V12, MEKK∆(K432M) or with pUC18 as a control. HA-STAT3 was immunoprecipitated from IL-6-stimulated cells using anti-HA antibodies and phosphorylation was analysed by Western blotting ( Figure 3C, lanes  5-10) . Co-expression of either dominant-negative Vav-C, dominant-negative RacN17 or dominant-negative MEKK∆(K432M) decreased both basal as well as IL-6-induced STAT3 Ser(#( phosphorylation, while STAT3 Tyr(!& phosphorylation was unaffected.
Taken together, these experiments demonstrate that IL-6-induced STAT3 transactivation as well as STAT3 Ser(#( phosphorylation are both dependent on activation of SEK-1\MKK-4 and the SEK-1\MKK-4-upstream components Vav, Rac-1 and MEKK-1.
The p38/MAPK pathway negatively regulates STAT3 transactivation and Ser 727 phosphorylation
To investigate the role of p38 in STAT3-dependent transactivation, the activity of pIRE LUC was analysed in the presence of the specific p38 inhibitor SB203580 following transient expression of this reporter in HepG2 cells. p38 activity was slightly increased in response to IL-6, but p38 kinase activity was completely blocked when cells were pre-incubated for 60 min in the presence of 1 µM SB203580 ( Figure 5A ). Inhibition of p38 activity had no effect on the level of IL-6 induction, which was approx. 5-fold as in control experiments ( Figure 5B ). These results indicate that IL-6-induced STAT3 transactivation does not require p38 activity. Interestingly, however, the absolute levels of luciferase activity increased significantly in the presence of SB203580, indicating that inhibition of p38 activity has an enhancing effect on pIRE LUC transactivation. Furthermore, pre-incubation with the chemical p38 inhibitor SB203580 revealed an increased basal level of STAT3 Ser(#( phosphorylation ( Figure 5C ). STAT3 Tyr(!& phosphorylation was unaffected by pre-incubating HepG2 cells with SB203580 ( Figure 5C ). These results indicate that p38 is not directly involved in IL-6-induced STAT3 Ser(#( phosphorylation, but rather negatively regulates STAT3 transactivation via a presently unknown mechanism.
DISCUSSION
STATs have been identified as a family of transcription factors that play an important role in stimulus-mediated gene expression in response to cellular stimulation by growth factors and cytokines [10] . Following ligand-receptor interaction, STATs become tyrosine phosphorylated, which allows STAT homo-or heterodimerization with other STAT family members, nuclear translocation and binding to specific consensus sequences of targetgene promoters [10] . For STAT3, a single tyrosine residue (Tyr(!&) is phosphorylated in response to EGF, interferon-γ and IL-6, which involves the intrinsic-or associated tyrosine kinases of growth factor or cytokine receptors [10, 11] . In addition, these Interleukin-6-induced STAT3 transactivation stimuli also induce STAT3 Ser(#( phosphorylation at the extreme STAT3 C-terminus [11, 12] . STAT3 Ser(#(, as well as the homologous residue in STAT1, has been shown to be required for maximal STAT-dependent transactivation [11] . In this report, we have investigated the kinase(s) involved in STAT3 Ser(#( phosphorylation in response to IL-6. Stimulation of HepG2 cells with IL-6 results in STAT3 Ser(#( phosphorylation within 10-15 min, which occurs with decreased kinetics when compared with the rapid STAT3 Tyr(!& phosphorylation which occurs within 5 min upon receptor activation. Interestingly, in localization studies we observed that STAT3 quickly translocated to the nucleus within 5 min upon IL-6 stimulation (results not shown), which is in agreement with previous reports [12] , suggesting that the Ser(#( phosphorylation mainly occurs in the nucleus.
In HepG2 cells, we observe that IL-6 induces ERK-1 activation (results not shown), which is in agreement with previously published studies [51, 52] . However, in our studies, using (i) the MEK inhibitor PD98059, (ii) overexpression of dominantnegative Raf, N∆Raf, and (iii) co-immunoprecipitation of STAT3 with ERK-1, we failed to demonstrate a direct involvement of ERKs in STAT3 transactivation or Ser(#( phosphorylation. In line with these findings, the C-terminal region of STAT3(379-770) containing Ser(#( was a very poor substrate for IL-6-activated ERK-1 in an in itro kinase assay (J.-J. Schuringa, L. J. C. Jonk, W. H. A. Dokter, E. Vellenga and W. Kruijer, unpublished work). These results indicate that IL-6-induced STAT3 Ser(#( phosphorylation in HepG2 cells is ERKindependent, in agreement with previously published reports [53] . In quiescent Swiss 3T3 cells, however, EGF-induced STAT3 Ser(#( phosphorylation has been shown to be dependent on activation of ERK-1 [53] . At present, we have no explanation for the different involvement of ERKs in STAT3 Ser(#( phosphorylation by these different factors. However, it may be possible that the timing of ERK activation is different in response to IL-6 and EGF or involves ERK compartmentalization in a way that is not compatible with IL-6-induced STAT3 Ser(#( phosphorylation. Further experiments are required to resolve this issue.
Our results demonstrate that IL-6 does not induce JNK activity in HepG2 cells as determined by kinase assays in itro. These results are further underscored by fluorescence confocal microscopy experiments, in which IL-6 did not stimulate nuclear translocation of JNK-1 (results not shown). Furthermore, no direct association between JNK-1 and STAT3 could be detected in co-immunoprecipitation studies (J. J. Schuringa, unpublished work). In addition, GST-STAT3(379-770) is not phosphorylated by immunoprecipitated JNK-1 from IL-6-or anisomycin-treated cells, indicating that the C-terminal part of STAT3 is a poor substrate for activated JNK-1. Taken together, these results demonstrate that JNK-1 is not mediating IL-6-induced STAT3 Ser(#( phosphorylation and transactivation.
In many cell types, SEK-1\MKK-4 is an upstream target for JNK-1 [54] . Surprisingly, in contrast to JNK, SEK-1\MKK-4 is quickly activated within 5-10 min upon IL-6 stimulation. Apparently, in HepG2 cells, IL-6-induced SEK-1\MKK-4 activation is not coupled to JNK-1 activation. However, SEK-1\MKK-4 activation is important in the IL-6-induced STAT3 transactivation, since overexpression of a dominant-negative mutant SEK-1\MKK-4(A-L) reduced IL-6-induced STAT3 transactivation in a dose-dependent manner and completely abolished IL-6-induced STAT3 Ser(#( phosphorylation, indicating that SEK-1\MKK-4 is an important mediator of IL-6-induced STAT3 transactivation. Although STAT3 Ser(#( phosphorylation was almost completely blocked by overexpression of dominant-negative SEK-1\MKK-4(A-L), the IL-6-induced STAT3 transactivation was only partially inhibited by overexpression of SEK-1\MKK-4(A-L). Possibly, there is still some residual Ser(#( phosphorylation which was undetectable in our Western blot analysis accounting for the residual transactivation of the pIRE LUC reporter. Clearly, overexpressed SEK-1\MKK-4(A-L) inhibited IL-6-induced STAT3 transactivation in a dose-dependent manner, and the residual transactivation of the pIRE LUC reporter will depend on the balance between overexpressed dominant-negative SEK-1\ MKK-4(A-L) and the endogenous SEK-1\MKK-4 which is present in HepG2 cells. Whether SEK-1\MKK-4 activates a kinase which phosphorylates STAT3 on Ser(#( or whether SEK-1\MKK-4 directly phosphorylates STAT3 is presently unknown and under investigation.
The observation that SEK-1\MKK-4 is involved in the IL-6-induced STAT3 Ser(#( phosphorylation is further underscored by experiments demonstrating the relevance of STAT3 transactivation by the SEK-1\MKK-4 upstream components Vav, Rac, and MEKK. Vav has been shown to be associated with the membrane-distal part of the gp130 transmembrane receptor in different cell types [35] [36] [37] Our investigations further demonstrate that p38 is not directly involved in STAT3 Ser(#( phosphorylation. In contrast, blocking p38 kinase activity with the chemical inhibitor SB203580 significantly increased the basal levels as well as the IL-6-induced STAT3 transactivation, while IL-6 was still capable of inducing an additional STAT3 transactivation of approx. 5-fold. The increase in transactivation in the presence of SB203580 was also coupled to an increased basal and IL-6-induced STAT3 Ser(#( phosphorylation levels, while STAT3 Tyr(!& phosphorylation was unaffected. Possibly, p38 squelches the activity of an upstream kinase like SEK-1\MKK-4, which is blocked in the presence of SB203580. This hypothesis is supported by recent results, showing that SEK-1\MKK-4 is indeed capable of binding and activating p38 [29, 50] and that p38 has an inhibiting effect on JNK-1-mediated Elk activation [33] . Whether the effects of SB203580 on STAT3 transactivation involve cross talk between the p38 and SAPK\JNK pathways requires further investigation.
In conclusion, these data indicate that IL-6-induced STAT3 transactivation and Ser(#( phosphorylation involves a gp130 receptor-signalling cascade that includes Vav, Rac-1, MEKK-1 and SEK-1\MKK-4 as signal transduction components.
